Loading...
By the Editors
This week, we reported on the CDC updating its list of contraindications to the two authorized mRNA COVID-19 vaccines and on the anaphylaxis rate with the Pfizer-BioNTech vaccine. Elsewhere, the FDA urged vaccine providers to stick to the current two-dose regimens — amid debate around whether stretching the time between the two doses, giving single doses, or giving two half doses might be beneficial. And finally, health officials reported on the new SARS-CoV-2 variant in several American states. Catch up on these and all of our COVID-19 stories from the past week at the links below.
Why We Chose This as Our Top Story
Andre Sofair, MD, MPH: With healthcare workers and high-risk individuals undergoing vaccination, I think that this week's articles give helpful information on dosing schedules, contraindications, and side effects of vaccination.
Comment
LINK(S):
COVID-19: Testing & Quarantine Duration? / College Campuses (Jan. 7) (Free)
CDC: Anaphylaxis with Pfizer-BioNTech COVID-19 Vaccine "Exceedingly Rare" (Jan. 6) (Free)
COVID-19: Convalescent Plasma Helps Prevent Disease Progression in Older Adults (Jan. 6) (Free)
FDA Sticks to Current COVID-19 Vaccine Schedules Amid Debates (Jan. 5) (Free)
COVID-19: Vaccine Contraindications / Mortality Risk Factors in Nursing Homes / AstraZeneca-Oxford Vaccinations (Jan. 4) (Free)
COVID-19: New Variant in U.S. / Half Doses of Vaccine? / Antigen Test Sensitivity (Jan. 3) (Free)